Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1)

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1)

 PREFACE 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):1

The importance of dosimetry in nuclear medicine therapy practice

Bisi G.


 FOREWORD DOSIMETRY IN NUCLEAR MEDICINE - PART I 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):2-4

Dosimetry in nuclear medicine therapy

Chiesa C., Lassmann M.


 FOREWORD DOSIMETRY IN NUCLEAR MEDICINE - PART I 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):5-20

Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?

Bardiès M., Buvat I.


 FOREWORD DOSIMETRY IN NUCLEAR MEDICINE - PART I 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):21-43

Quantitative imaging of 124I with PET/ CT in pretherapy lesion dosimetry Effects impairing image quantification and their corrections

Jentzen W., Freudenberg L., Bockisch A.


 FOREWORD DOSIMETRY IN NUCLEAR MEDICINE - PART I 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):44-56

From imaging to dosimetry and biological effects

Konijnenberg M.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):57-65

Could [18]F-fluorodeoxyglucose PET/CT change the therapeutic management of stage IV thyroid cancer with positive 131I whole body scan?

Piccardo A., Foppiani L., Morbelli S., Bianchi P., Barbera F., Biscaldi E., Altrinetti V., Villavecchia G., Cabria M.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):66-71

Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of 67Ga imaging and 18F-FDG PET

Keijsers R. G., Grutters J. C., Thomeer M., Du Bois R. M., Van Buul M. M., Lavalaye J., Van Den Bosch J. M., Verzijlbergen F. J.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):72-80

Prognostic role of the PET parameter maximum standardized uptake value in non small cell lung cancer: analysis in tumour of diameter ≥ and <25 mm

Pelosi E., Billè A., Skanjeti A., Errico L., Arena V., Ardissone F., Borasio P., Mancini M.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):81-90

[18F]FDG-PET/CT monitoring early identifies advan-ced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy

Martoni A. A., Fanti S., Zamagni C., Rosati M., De Iaco P., D’Errico Grigioni A., Castellucci P., Quercia S., Musto A., Ricci Maccarini L., Lopci E., Bernardi A.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):91-102

Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after 186Re-HEDP therapy

Zafeirakis A., Zissimopoulos A., Baziotis N., Limouris G. S.


 LETTERS TO THE EDITOR 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 Febbraio;55(1):103-4

Technetium-99m supply shortage. Possible solutions in every day nuclear cardiology practice

Marcassa C., Campini R., Zoccarato O., Calza P.


inizio pagina